Trial Profile
A study investigating the long term (96 weeks) effect of telbivudine in hepatitis B virus-related decompensated and compensated patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 Dec 2015 New trial record